Is there a role for dehydroepiandrosterone replacement in the intensive care population?

Intensive Care Medicine

Volumn 29, Issue 11, 2003, Pages 1877-1880

  Dhatariya, Ketan K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCAGON; HYDROCORTISONE; MUSCLE PROTEIN; PRASTERONE;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; CLINICAL TRIAL; ENZYME ACTIVITY; HUMAN; INTENSIVE CARE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NOTE;

ADJUVANTS, IMMUNOLOGIC; ADRENAL INSUFFICIENCY; AGE FACTORS; CRITICAL ILLNESS; DEHYDROEPIANDROSTERONE; EVIDENCE-BASED MEDICINE; HORMONE REPLACEMENT THERAPY; HUMANS; INTENSIVE CARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0344394239     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-1981-y     Document Type: Note

References (28)

1. Barquist E, Kirton O (1997) Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 42:27-31
2. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871
3. Zipser RD, Davenport MW, Martin KL, Tuck ML, Warner NE, Swinney RR, Davis CL, Horton R (1981) Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab 53:867-873
4. Findling JW, Waters VO, Raff H (1987) The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 64:592-595
5. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Nagy A, Schuetz A, Lamm P, Knoll A, Peter K (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31:1068-1074
6. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723-732
7. Labrie F (1991) Intracrinology. Mol Cell Endocrinol 78:C113-118
8. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
9. Hornsby PJ (2002) Aging of the human adrenal cortex. Ageing Res Rev 1:229-242
10. Dhatariya K, Nair KS (2003) DHEA -Is there a role for replacement? Mayo Clin Proc (in press):
11. Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80:1238-1242
12. Schroeder S, Wichers M, Klingmuller D, Hofer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stuber F (2001) The hypothalamic-pituitary- adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 29:310-316
13. Annane D (2001) Corticosteroids for septic shock. Crit Care Med 29:S117-120
14. Marx C, Petros S, Bornstein SR, Weise M, Wendt M, Menschikowski M, Engelmann E, Höffken G (2003) Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol. Crit Care Med 31:1382-1388
15. Beishuizen A, Thijs LG, Vermes I (2002) Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 6:434-438
16. Delpedro AD, Barjavel MJ, Mamdouh Z, Bakouche O (1998) Activation of human monocytes by LPS and DHEA. J Interferon Cytokine Res 18:125-135
17. Blauer KL, Poth M, Rogers WM, Bernton EW (1991) Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174-3179
18. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL, Daynes RA (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42:293-304
19. Oberbeck R, Dahlweid M, Koch R, van Griensven M, Emmendorfer A, Pape HC (2001) Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 29:380-384
20. Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61:202-211
21. Casson PR, Andersen RN, Herrod HG, Stentz FB, Straughn AB, Abraham GE, Buster JE (1993) Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169:1536-1539
22. Morales AJ, Nolan JJ, Nelson JC, Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
23. Montori VM, Bistrian BR, McMahon MM (2002) Hyperglycemia in Acutely Ill Patients. JAMA 288:2167-2169
24. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Bouillon R, Lauwers P (2001) Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 345:1359-1367
25. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R (1999) Reactivation of Pituitary Hormone Release and Metabolic Improvement by Infusion of Growth Hormone-Releasing Peptide and Thyrotropin-Releasing Hormone in Patients with Protracted Critical Illness. J Clin Endocrinol Metab 84:1311-1323
26. Shepherd A, Cleary MP (1984) Metabolic alterations after dehydroepiandrosterone treatment in Zucker rats. Am J Physiol Endocrinol Metab 246:E123-128
27. Kajita K, Ishizuka T, Miura A, Ishizawa M, Kanoh Y, Yasuda K (2000) The role of atypical and conventional PKC in dehydroepiandrosterone-induced glucose uptake and dexamethasone-induced insulin resistance. Biochem Biophys Res Commun 277:361-367
28. Herranz L, Megia A, Grande C, Gonzalez-Gancedo P, Pallardo F (1995) Dehydroepiandrosterone sulphate, body fat distribution and insulin in obese men. Int J Obes Relat Metab Disord 19:57-60